You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Test Information
Home / Tests / Healthcare Associated Infections / Xpert C. difficile/Epi

Xpert® C. difficile/Epi

45-minute detection & differentiation of Clostridium difficile & the Epidemic 027 strain

Xpert<sup>®</sup>&nbsp;<em>C. difficile/Epi</em>

Xpert® C. difficile/Epi — Identify. Differentiate. Prevent.

The epidemic strain of Clostridium difficile (027/NAP1/BI) is known to produce a significantly higher number of C. difficile spores and toxins. The epidemic strain has also been identified as a cause of hospital outbreaks worldwide. Healthcare professionals can now be informed on the epidemic C. difficile strain and make appropriate infection control decisions.

The Need

Numerous outbreaks caused by the epidemic strain of C. difficile (027/NAP1/BI strain) highlight the need for rapid and accurate differentiation of C. difficile 027/NAP1/BI strains in order to stay ahead of an outbreak.

  • Higher risk of cross contamination with 027/NAP1/BI strain due to more efficient sporulation1,2,3
  • 027/NAP1/BI strain has been identified as a cause of outbreaks around the world4,5,6,7,8
  • Incremental costs due to C. difficile infection can be as high as $7,1799 per patient

1. Åkerlund T, et al. Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol. Apr 2008, 46 (4) 1530-1533. 

2. Warny M, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005 Sep 24-30;366(9491):1079-84.

3. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006 Nov 21;145(10):758-64.

4. Kallen AJ, et al. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol. 2009 Mar;30(3):264-72.

5. Kuijper EJ, et al. Update of Clostridium difficile-associated Disease due to PCR Ribotype 027 in Europe. Eurosurveillance. Apr–Jun 2007. 12(3-6):163-166.

6. Muto CA, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis. 2007 Nov 15;45(10):1266-73.

7. McDonald LC, et al. An Epidemic, Toxin Gene-variant Strain of Clostridium difficile. N Engl J Med. 2005 Dec 8;353(23):2433-41.

8. Loo VG, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005 Dec 8;353(23):2442

9. Jarvis WR, et al. National Point Prevalence of Clostridium difficile in US Health Care Facility Inpatients, 2008. Am J Infect Control. 2009 May;37(4):263-70.

10. Xpert® C. difficile/Epi Package Insert. 300-9680, Rev J. Apr 2020.

The Solution

Xpert C. difficile/Epi is the first commercially available test in the world to detect and differentiate the epidemic strain of C. difficile (027/NAP1/BI). With rapid and accurate identification of epidemic strain, Infection Control professional can stay ahead of potential outbreak situation.

  • Innovative multiplex design enables detection of C. difficile Infection (CDI) and 027/NAP1/BI strain call-out in a single cartridge
  • On-Demand testing of samples from suspected CDI patients provides On-Demand epidemiological surveillance data clinicians can act on
  • Monitoring and reporting of the epidemic strain enables clinicians to improve infection control efforts

Cepheid's Xpert C. difficile/Epi test provides on-demand results you can trust and empowers your clinical team to better manage patients.

Ordering Info

Xpert® C. difficile/Epi

Number of Tests: 10

Catalog #: GXCDIFF/EPI-10

Educational Materials

Back to Top